Plasma Norepinephrine and Dopamine Levels in Prepubertal Male Children with Attention-Deficit Hyperactivity Disorder do not Change with 8 Weeks of Methylphenidate Treatment

References

• Banaschewski T, Coghill D. Phenomenology. In Attention- Deficit/Hyperactivity Disorder and Hyperkinetic Disorder, Banaschewski T, Coghill D, Danckaerts M, Döpfner M, Rohde L, Sergeant JA. (editors). Oxford: Oxford University Press, 2010. p. 3–18. [CrossRef]
   Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164(6): 942–8. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007; 190: 402–9. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Matthysse S. Dopamine and selective attention. Adv Biochem Psychopharmacol 1977; 16: 667–9.
   Google Scholar
• Mason ST, Fibiger HC. Evidence for a role of brain noradrenaline in attention and stimulus sampling. Brain Res 1978; 159(2): 421–6. [CrossRef]
   Web of Science ®Google Scholar
• Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 2011; 69(12): e145–57. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Gurvich C, Rossell SL. Dopamine and cognitive control: sex-by-genotype interactions influence the capacity to switch attention. Behav Brain Res 2015; 281: 96–101. [CrossRef]
   Web of Science ®Google Scholar
• Bollmann S, Ghisleni C, Poil SS, Martin E, Ball J, Eich-Höchli D, et al. Developmental changes in gamma-aminobutyric acid levels in attention deficit/hyperactivity disorder. Transl Psychiatry. 2015; 5: e589. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Paclt I, Koudelová J, Krepelová A, Uhlíková P, Gazdíková M, Bauer P. Biochemical markers and genetic research of ADHD. Neuro Endocrinol Lett 2005; 26(4): 423–30.
   Web of Science ®Google Scholar
• Thome J, Ehlis AC, Fallgatter AJ, Krauel K, Lange KW, Riederer P, et al. Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD. World J Biol Psychiatry 2012; 13(5): 379–400. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Wallis D. The search for biomarkers for attention deficit/hyperactivity disorder. Drug News Perspect 2010; 23(7): 438–49.
   Google Scholar
• Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ. Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997; 16(4): 276–84. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Ionescu G, Kiehl R, Ona L, Wichmann-Kunz F. Abnormal plasma catecholamines in hyperkinetic children. Biol Psychiatry 1990; 28(6): 547–50. [CrossRef]
   Web of Science ®Google Scholar
• Girardi NL, Shaywitz SE, Shaywitz BA, Marchione K, Fleischman SJ, Jones TW, et al. Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder. Pediatr Res 1995; 38(4): 539–42. [CrossRef]
   Web of Science ®Google Scholar
• Wigal SB, Nemet D, Swanson JM, Regino R, Trampush J, Ziegler MG, et al. Catecholamine response to exercise in children with attention deficit hyperactivity disorder. Pediatr Res 2003; 53(5): 756–61. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Scassellati C, Bonvicini C, Faraone SV, Gennarelli M. Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry 2012; 5110): 1003–19.
   Google Scholar
• Dvoráková M, Jezová D, Blazícek P, Trebatická J, Skodácek I, Suba J, et al. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). Nutr Neurosci 2007; 10(3–4): 151–7. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Elia J, Kruesi MJ, Marsh WL, Gulotta CS, Potter WZ, et al. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology 1996; 14(2): 125–37. [CrossRef]
   Web of Science ®Google Scholar
• Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36(7): 980–8. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Gokler B, Unal F, Pehlivanturk B. Kultur EC, Akdemir D, Taner Y. Reliability and Validity of Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version—Turkish version (K-SADS-PL-T). Turk J Child Adolesc Ment Health 2004; 11(3): 109–16. (Turkish)
   Google Scholar
• Wechsler D. WISC-R Manual for the Wechsler Intelligence Scale for Children—Revised, New York: Published by Psychological Corporation, 1974.
   Google Scholar
• Savasir I, Sahin N. Manual for the Wechsler Intelligence Scale for Children—Revised (WISC-R), Ankara: Published by Turkish Psychology Association Publication, 1995. (Turkish)
   Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology—Revised (DHEW Publ No ADM 76–338), Rockville: Published by U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976 p. 218–22.
   Google Scholar
• Du Paul GJ. Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample. J Clin Child Psychol 1991; 20(3): 245–53. [CrossRef]
   Google Scholar
• Pekcanlar A, Turgay A, Miral S. Baykara A. Family Functioning in Attention-Deficit Hyperactivity Disorder. Turk J Child Adolesc Ment Health 1999; 6(2): 99–107. (Turkish)
   Google Scholar
• Lucot JB, Jackson N, Bernatova I, Morris M. Measurement of plasma catecholamines in small samples from mice. J Pharmacol Toxicol Methods 2005; 52(2): 274–7. [CrossRef]
   Google Scholar
• Reis F, Tavares P. Teixeira F. The distribution of catecholamines between plasma and platelets in cyclosporin A-induced hypertensive rats. Pharmacol Res 2000; 41(2): 129–35. [CrossRef]
   Web of Science ®Google Scholar
• Verhulst FC, Van der Ende J. Rating Scales. In Child and Adolescent Psychiatry, Rutter M, Taylor E (editors). 4th ed. Massachusetts: Blackwell Science, 2002. p. 70–86.
   Google Scholar